Welcome - Register - Login - Help/FAQ - 0 items

Search Enter keywords, a title or a report id number below. In All Categories --------------------- Telecom & Computing Business & Finance Mfg & Construction Pharma & Healthcare Consumer & Retail Gov & Public Sector Energy & Transport Country Reports Company Reports --------------------- Transcripts Advanced      Select a currency for use throughout the site Australia Dollars Canada Dollars Euro Japan Yen Sweden Kroner Switzerland Francs UK Pounds US Dollars Search Results Your Search for 'Protein Microarrays: Technology Adoption' returned 41 results - Page 1 of 3   Sort by    Date Published ASC Date Published DESC Report Price ASC Report Price DESC Rank ASC Rank DESC   Sorted by Rank Top-Bottom Microarray Markets   TriMark Publications, Sep 2008, Pages: 132 Users 38 4.6 Reasons Why Researchers Utilize Protein Microarrays 39 4.7 Factors for Adoption of Protein Microarrays Technology 39 4.8 Top Suppliers of Protein Microarray Slides and Products 40 4 Biochips - Products, Applications, Technologies and End-Use Markets Growth Analysis, 2009-2015   Axis Research Mind, Feb 2011, Pages: 599 . This industry is expected to bring rapid and significant changes in the life sciences and medicine. Microarray technology has a great potential and is widely used in DNA and protein analysis. I. REPORT FOCUS Biochips Market (DNA Microarrays, Lab-on-Chip, Protein Microarrays, Tissue & Cell Arrays) Trends & Global Forecast (2010-2015)   Markets and Markets, Aug 2011, Pages: 278 adoption by various biotechnology, pharmaceutical companies, and research laboratories. The third largest segment – protein microarrays will be the fastest growing segment; forecasted to grow at a CAGR of 19 Beyond Expression Arrays: Emerging Applications for Genomic Microarray Technology   Beachhead Consulting, Sep 2006 .1 FDA Microarray Quality Control (MAQC) Project 6 Conclusion and potential for adoption 7 Companies/Institutions involved in Microarray Technology 8 Company Profiles List of Figures Figure 1 Personalized Medicine - Scientific and Commercial Aspects   Jain PharmaBiotech, Feb 2012, Pages: 780 Significance of mitochondrial proteome in human disease Proteomic technologies for drug discovery and development Role of reverse-phase protein microarray in drug discovery Role of proteomics in clinical drug Technology Developments in Functional Proteomics (Technical Insights)   Frost & Sullivan, Sep 2006 diagnostics and antibody therapies, enabling technologies, spectometry, microarrays, electrophoresis, immunohistochemistry, yeast and viral expression and identification, affinity chromatography Innovations in Molecular Diagnostics for Infectious Diseases   Business Insights, Nov 2011, Pages: 168 Introduction MDx opportunities in viral hemorrhagic fevers MDx opportunities in other emerging pathogens Multiplexed MDx technology trends Microarrays and microfluidic devices Mass spectrometry Widening adoption Bioinformatics Market - Advanced Technologies, Global Forecast and Winning Imperatives (2009 - 2014)   Markets and Markets, July 2010, Pages: 272 . Bioinformatics uses information technology, statistics, and algorithms to integrate biological data. Pharmaceutical companies are now adopting automated technologies to manufacture effective therapies and drugs Top 10 Drug Discovery Technologies – Strategic Analysis And Global Forecasts   Markets and Markets, Nov 2010, Pages: 311 is a major concern which the drug development companies are catering to by using these top technologies. The increasing utilization of HTS in the lead generation and increasing adoption of the technology The Global Bioinformatics Market: Market Size, Forecasts and Company Profiles   Business Insights, Sep 2009, Pages: 266 of pathways Protein annotation Automatic alerts for related new sequences 3D structure analysis and modeling tools 3D viewers 3D homology modeling 3D analysis RNA analysis tool Microarray data analysis Innovations in Bioinformatics: Emerging Tools for Drug Discovery and Development   Business Insights, Jan 2008, Pages: 253 as a catalyst for this expansion. - Knowledge management is currently the leading bioinformatics market segment. This lead will be strengthened by mass adoption of Semantic Web technology and the increasing U.S. Microfluidics/Lab-on-a-chip Markets   Frost & Sullivan, May 2006 : - DNA/RNA - Protein - Cell Market Overview Microfluidics technology has gained importance in the healthcare business with response to the immense growth in the areas of genomics, high-throughput RNAi - Technologies, Markets and Companies   Jain PharmaBiotech, Feb 2012, Pages: 485 RNA Protamine-antibody fusion proteins for delivery of siRNA to cells Protein transduction domains Phosphorothioate stimulated cellular delivery of siRNA Targeted delivery of siRNAs by lipid-based technologies Biomarker Technology Platforms for Cancer Diagnoses and Therapies   TriMark Publications, Sep 2011, Pages: 343 . Protein biomarkers are also useful. The purpose of this TriMark Publications report is to describe the specific segment of the cancer diagnostics market which develops new biomarker technology platforms Companion Biomarkers in Drug Development   TriMark Publications, April 2009, Pages: 320 Protein Microarrays 74 3.2.4.2 Factors for Adoption of Protein Microarrays Technology 74 3.2.4.3 Future Innovations in Protein Microarray Technology 74 3.2.5 New Technologies 75 3.2.5.1 Antibody Microarrays Cancer Bundle   TriMark Publications, May 2011, Pages: 1784 -generation biochips and microfluidics, next-generation signal detection, biosensors and molecular labels, and gene expression profiling using microarrays. These technologies are improving the discovery Molecular Diagnostics in Cancer Testing   TriMark Publications, July 2011, Pages: 214 labels, and gene expression profiling using microarrays. These technologies are improving the discovery of therapeutic molecules for cancer, the screening, diagnosis and classification of cancer patients Assessment of Innovations in Biochips   Frost & Sullivan, March 2009, Pages: 85 Industry-II - - SWOT Analysis of the Biochip Industry - - Economics of Competitive Rivalry and Technology Adoption Curve - - Current Industry Trends and Strategic Positioning of Participants in the Biochip Biomarkers - Advanced Technologies and Global Market (2009-2014)   Markets and Markets, Sep 2009, Pages: 256 4.6.4. Restraints 4.6.4.1. Expensive proteomics analysis tools leads to low adoption rates 4.6.4.2. Technological need for speeding up validation process 4.6.5. Mass Spectrometry in Biomarker Discovery U.S. Epigenetics Markets   Frost & Sullivan, Dec 2009, Pages: 111 proteins. Chromatin immunoprecipitation is often performed with complete ChIP kits and is usually followed by either quantitative polymerase chain reaction (PCR), microarray technology (ChIP-on-chip or Ch Results:  First -   Prev -   1 -   2 -   3 -   Next -   Last

		For enquiries please call us on:   +353-1-415-1241 (GMT Office Hours)   1-800-526-8630 (US/Canada Toll Free)   1-917-300-0470 (EST Office Hours)

All rights reserved. © Copyright 2012 Research and Markets1    Terms and conditions Privacy Policy Publishers Employment Opportunities Site Map Link to us Webmaster Affiliate Network